BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Camargo SMR, Vuille-dit-bille RN, Mariotta L, Ramadan T, Huggel K, Singer D, Götze O, Verrey F. The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease. J Pharmacol Exp Ther 2014;351:114-23. [DOI: 10.1124/jpet.114.216317] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Muddapu VR, Vijayakumar K, Ramakrishnan K, Chakravarthy VS. A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease. Front Neurosci 2022;16:797127. [DOI: 10.3389/fnins.2022.797127] [Reference Citation Analysis]
2 Hansen CA, Miller DR, Annarumma S, Rusch CT, Ramirez-Zamora A, Khoshbouei H. Levodopa-induced dyskinesia: a historical review of Parkinson's disease, dopamine, and modern advancements in research and treatment. J Neurol 2022. [PMID: 35039902 DOI: 10.1007/s00415-022-10963-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Boelens Keun JT, Arnoldussen IA, Vriend C, van de Rest O. Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review. Adv Nutr 2021;12:2265-87. [PMID: 34113965 DOI: 10.1093/advances/nmab060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Nataf S, Pays L. Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis. Int J Mol Sci 2021;22:10440. [PMID: 34638785 DOI: 10.3390/ijms221910440] [Reference Citation Analysis]
5 Adamiak-Giera U, Jawień W, Pierzchlińska A, Białecka M, Kobierski JD, Janus T, Gawrońska-Szklarz B. Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications. Pharmaceutics 2021;13:1395. [PMID: 34575471 DOI: 10.3390/pharmaceutics13091395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Maric S, Restin T, Muff JL, Camargo SM, Guglielmetti LC, Holland-Cunz SG, Crenn P, Vuille-Dit-Bille RN. Citrulline, Biomarker of Enterocyte Functional Mass and Dietary Supplement. Metabolism, Transport, and Current Evidence for Clinical Use. Nutrients 2021;13:2794. [PMID: 34444954 DOI: 10.3390/nu13082794] [Reference Citation Analysis]
7 Aslanoglou D, Bertera S, Sánchez-Soto M, Benjamin Free R, Lee J, Zong W, Xue X, Shrestha S, Brissova M, Logan RW, Wollheim CB, Trucco M, Yechoor VK, Sibley DR, Bottino R, Freyberg Z. Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors. Transl Psychiatry 2021;11:59. [PMID: 33589583 DOI: 10.1038/s41398-020-01171-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
8 Camargo SMR, Vuille-Dit-Bille RN, Meier CF, Verrey F. ACE2 and gut amino acid transport. Clin Sci (Lond). 2020;134:2823-2833. [PMID: 33140827 DOI: 10.1042/cs20200477] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
9 Senek M, Nyholm D, Nielsen EI. Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism. Sci Rep 2020;10:18057. [PMID: 33093598 DOI: 10.1038/s41598-020-75052-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Meier CF, Camargo SMR, Hunziker S, Leu S, Holland-Cunz SG, Verrey F, Vuille-Dit-Bille RN. Mucosal Monosaccharide Transporter Expression in Newborns With Jejunoileal Atresia and Along the Adult Intestine. J Pediatr Gastroenterol Nutr 2019;69:611-8. [PMID: 31261244 DOI: 10.1097/MPG.0000000000002425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Maric S, Flüchter P, Guglielmetti LC, Staerkle RF, Sasse T, Restin T, Schneider C, Holland-Cunz SG, Crenn P, Vuille-Dit-Bille RN. Plasma citrulline correlates with basolateral amino acid transporter LAT4 expression in human small intestine. Clin Nutr 2021;40:2244-51. [PMID: 33077272 DOI: 10.1016/j.clnu.2020.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Di L, Artursson P, Avdeef A, Benet LZ, Houston JB, Kansy M, Kerns EH, Lennernäs H, Smith DA, Sugano K. The Critical Role of Passive Permeability in Designing Successful Drugs. ChemMedChem 2020;15:1862-74. [PMID: 32743945 DOI: 10.1002/cmdc.202000419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
13 Choudhury RA, Yoeli D, Hoeltzel G, Moore HB, Prins K, Kovler M, Goldstein SD, Holland-cunz SG, Adams M, Roach J, Nydam TL, Vuille-dit-bille RN. STEP improves long-term survival for pediatric short bowel syndrome patients: A Markov decision analysis. Journal of Pediatric Surgery 2020;55:1802-8. [DOI: 10.1016/j.jpedsurg.2020.03.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Prakash N, Simuni T. Infusion Therapies for Parkinson’s Disease. Curr Neurol Neurosci Rep 2020;20. [DOI: 10.1007/s11910-020-01062-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Takeshige-Amano H, Saiki S, Fujimaki M, Ueno SI, Li Y, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Tsunemi T, Daida K, Ishiguro Y, Imamichi Y, Nanmo H, Nojiri S, Funayama M, Hattori N. Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. Mov Disord 2020;35:1438-47. [PMID: 32357260 DOI: 10.1002/mds.28068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zadikoff C, Poewe W, Boyd JT, Bergmann L, Ijacu H, Kukreja P, Robieson WZ, Benesh J, Antonini A. Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa. Parkinsons Dis 2020;2020:9716317. [PMID: 32104560 DOI: 10.1155/2020/9716317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Leipziger J, Praetorius H. Renal Autocrine and Paracrine Signaling: A Story of Self-protection. Physiol Rev 2020;100:1229-89. [PMID: 31999508 DOI: 10.1152/physrev.00014.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 van Kessel SP, El Aidy S. Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease. Front Neurol 2019;10:1087. [PMID: 31681153 DOI: 10.3389/fneur.2019.01087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
19 Farino ZJ, Morgenstern TJ, Maffei A, Quick M, De Solis AJ, Wiriyasermkul P, Freyberg RJ, Aslanoglou D, Sorisio D, Inbar BP, Free RB, Donthamsetti P, Mosharov EV, Kellendonk C, Schwartz GJ, Sibley DR, Schmauss C, Zeltser LM, Moore H, Harris PE, Javitch JA, Freyberg Z. New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion. Mol Psychiatry 2020;25:2070-85. [PMID: 30626912 DOI: 10.1038/s41380-018-0344-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
20 Villageliú D, Lyte M. Dopamine production in Enterococcus faecium: A microbial endocrinology-based mechanism for the selection of probiotics based on neurochemical-producing potential. PLoS One 2018;13:e0207038. [PMID: 30485295 DOI: 10.1371/journal.pone.0207038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
21 Tambasco N, Romoli M, Calabresi P. Levodopa in Parkinson's Disease: Current Status and Future Developments. Curr Neuropharmacol 2018;16:1239-52. [PMID: 28494719 DOI: 10.2174/1570159X15666170510143821] [Cited by in Crossref: 52] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
22 Mittur A, Gupta S, Modi NB. Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa. Clin Pharmacokinet 2017;56:999-1014. [PMID: 28236251 DOI: 10.1007/s40262-017-0511-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
23 Müller T, Möhr J. Long-term management of Parkinson’s disease using levodopa combinations. Expert Opinion on Pharmacotherapy 2018;19:1003-11. [DOI: 10.1080/14656566.2018.1484108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Ikeda M, Iijima H, Shinoda I, Iwamoto H, Takeda Y. Effects of bovine lactoferrin on l-DOPA absorption and metabolism in mice. Food Funct 2018;9:2865-71. [PMID: 29707715 DOI: 10.1039/c7fo01518f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Radwan A, Sweileh A, Shraim W, Hroub A, Elaraj J, Shraim N. Evaluation of community pharmacists’ knowledge and awareness of food–drug interactions in Palestine. Int J Clin Pharm 2018;40:668-75. [DOI: 10.1007/s11096-018-0640-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Xu J, Lin Y, Boulas P, Peterson ML. Low colonic absorption drugs: risks and opportunities in the development of oral extended release products. Expert Opin Drug Deliv 2018;15:197-211. [PMID: 28988504 DOI: 10.1080/17425247.2018.1389889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
27 Murakami T. Absorption sites of orally administered drugs in the small intestine. Expert Opin Drug Discov 2017;12:1219-32. [PMID: 28920464 DOI: 10.1080/17460441.2017.1378176] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
28 Taslimifar M, Oparija L, Verrey F, Kurtcuoglu V, Olgac U, Makrides V. Quantifying the relative contributions of different solute carriers to aggregate substrate transport. Sci Rep 2017;7:40628. [PMID: 28091567 DOI: 10.1038/srep40628] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
29 Takahashi A, Okumura J, Morita Y, Chiji H. Intestinal Absorption and Antioxidant Activity of Betalain: A Nitrogen-containing Pigment from Table Beets and Cactus Pear Fruit Juice. JOURNAL OF THE JAPANESE SOCIETY FOR FOOD SCIENCE AND TECHNOLOGY 2017;64:51-8. [DOI: 10.3136/nskkk.64.51] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
30 Murakami T. A Minireview: Usefulness of Transporter-Targeted Prodrugs in Enhancing Membrane Permeability. Journal of Pharmaceutical Sciences 2016;105:2515-26. [DOI: 10.1016/j.xphs.2016.05.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
31 Miyauchi E, Tachikawa M, Declèves X, Uchida Y, Bouillot J, Poitou C, Oppert J, Mouly S, Bergmann J, Terasaki T, Scherrmann J, Lloret-linares C. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects. Mol Pharmaceutics 2016;13:2631-40. [DOI: 10.1021/acs.molpharmaceut.6b00085] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 8.5] [Reference Citation Analysis]
32 Kang YS, Jung HJ, Oh JS, Song DY. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease. CNS Neurosci Ther 2016;22:817-23. [PMID: 27350533 DOI: 10.1111/cns.12580] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
33 Guebila MB, Thiele I. Model-based dietary optimization for late-stage, levodopa-treated, Parkinson's disease patients. NPJ Syst Biol Appl 2016;2:16013. [PMID: 28725472 DOI: 10.1038/npjsba.2016.13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
34 Wei L, Tominaga H, Ohgaki R, Wiriyasermkul P, Hagiwara K, Okuda S, Kaira K, Oriuchi N, Nagamori S, Kanai Y. Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging. Cancer Sci. 2016;107:347-352. [PMID: 26749017 DOI: 10.1111/cas.12878] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
35 Nagashima Y, Kondo T, Sakata M, Koh J, Ito H. Effects of soybean ingestion on pharmacokinetics of levodopa and motor symptoms of Parkinson's disease — In relation to the effects of Mucuna pruriens. Journal of the Neurological Sciences 2016;361:229-34. [DOI: 10.1016/j.jns.2016.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
36 Pretorius E, Swanepoel AC, Buys AV, Vermeulen N, Duim W, Kell DB. Eryptosis as a marker of Parkinson's disease. Aging (Albany NY) 2014;6:788-819. [PMID: 25411230 DOI: 10.18632/aging.100695] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 7.6] [Reference Citation Analysis]